AdaptHealth Corp.
$12.67
▲
1.43%
2026-04-21 05:09:01
adapthealth.com
NCM: AHCO
Explore AdaptHealth Corp. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$1.72 B
Current Price
$12.67
52W High / Low
$12.87 / $7.11
Stock P/E
—
Book Value
$11.46
Dividend Yield
—
ROCE
5.17%
ROE
-4.25%
Face Value
—
EPS
$-0.52
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Devices
Employees
10,900
Beta
1.5
Debt / Equity
124.67
Current Ratio
1.02
Quick Ratio
0.81
Forward P/E
9.83
Price / Sales
0.51
Enterprise Value
$3.46 B
EV / EBITDA
5.9
EV / Revenue
1.07
Rating
None
Target Price
$12.88
EPS Forecast (FY)
—
Pros
- Valuation is not stretched on P/E basis.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Inspire Medical Systems, Inc. | $56.97 | 11.28 | $1.64 B | — | 6.28% | 19.77% | $163.35 / $48.3 | $27.33 |
| 2. | IceCure Medical Ltd | $0.36 | — | $24.87 M | — | -166.53% | -1.89% | $1.4 / $0.28 | $0.12 |
| 3. | Adagio Medical Holdings, Inc. | $1.53 | — | $34.43 M | — | -62.51% | -1.55% | $2.87 / $0.74 | $0.56 |
| 4. | PAVmed Inc. | $9.44 | 150.27 | $60.26 M | — | -89.22% | -32.34% | $28.44 / $6 | $10.01 |
| 5. | Pulsenmore Ltd. | $3.33 | — | $72.38 M | — | -33.09% | -17.62% | $1,468 / $1,000 | — |
| 6. | NeuroOne Medical Technologies Corporation | $4.98 | — | $40.89 M | — | -49.83% | -1.46% | $6.96 / $3 | $0.13 |
| 7. | iTonic Holdings Ltd. | $0.32 | — | $5.41 M | — | -59.82% | -71.25% | $32 / $0.25 | $0.36 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 1.47 B | 602.63 M | 591.81 M | 580.47 M | 1.47 B | — |
| Operating Profit | 34.14 M | 67.13 M | 47.03 M | 23.17 M | 76.67 M | — |
| Net Profit | -102.77 M | 24.51 M | 14.67 M | -7.21 M | 50.26 M | — |
| EPS in Rs | -0.76 | 0.18 | 0.11 | -0.05 | 0.37 | — |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 3.24 B | 3.26 B | 3.2 B | 2.97 B |
| Operating Profit | 186.27 M | 276.81 M | 232.39 M | 190.41 M |
| Net Profit | -70.79 M | 90.42 M | -678.89 M | 69.32 M |
| EPS in Rs | -0.52 | 0.67 | -5 | 0.51 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 4.32 B | 4.49 B | 4.51 B | 5.22 B |
| Total Liabilities | 2.79 B | 2.91 B | 3.04 B | 3.06 B |
| Equity | 1.52 B | 1.57 B | 1.46 B | 2.15 B |
| Current Assets | 728.9 M | 755.79 M | 649.02 M | 585.31 M |
| Current Liabilities | 712.39 M | 566.99 M | 537 M | 456.21 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | 601.77 M | 541.84 M | 480.67 M | 373.87 M |
| Investing CF | -303.19 M | -310.27 M | -357.28 M | -411.17 M |
| Financing CF | -302.19 M | -198.95 M | -92.53 M | -66.05 M |
| Free CF | 219.38 M | 235.78 M | 143.2 M | -17.56 M |
| Capex | -382.39 M | -306.06 M | -337.46 M | -391.42 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | 1.9% | 7.73% | — | — |
| Earnings Growth % | 113.32% | -1079.42% | — | — |
| Profit Margin % | 2.77% | -21.21% | 2.33% | — |
| Operating Margin % | 8.49% | 7.26% | 6.41% | — |
| Gross Margin % | 20.89% | 19.5% | 19.53% | — |
| EBITDA Margin % | 19.26% | -6.58% | 18.8% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.